Hydration Pharmaceuticals Company LimitedASX: HPC

Q3 FY26 Quarterly Activities Report (App 4C)

· Issued by Hydration Pharmaceuticals Company Limited via ASX

Filed with ASX ·

743 Prospect Street La Jolla CA 92037 Company Announcement — ASX: HPC 30 October 2026 Quarterly Activities Report and Appendix 4C — quarter ended 30 September 2026 Hydralyte LLC records maiden monthly profit; quarterly operating loss cut 85% HIGHLIGHTS • Operating loss down 85%: Hydralyte LLC...

View Attachment

6ix is reading this filing.

Hydration Pharmaceuticals Company Limited on 6ix

Story so far

Earlier from Hydration Pharmaceuticals

All Hydration Pharmaceuticals news releases